Method for Optimizing Blood Cell Transplants
The invention relates to the use of allogenic T lymphocytes for the preparation of a composition intended to be injected into a recipient patient as conditioning for a hematopoietic stem cell transplant, said allogenic T lymphocytes expressing a molecule enabling the specific destruction thereof.
Patents:WO 2,009,053,631
Inventor(s):
KLATZMANN DAVID [FR]; COHEN JOSE [FR]
Type of Offer:
Sale
« More Medical Patents